Please assess the completion status of the following clinical trial:

Trial Title: Open Label Safety Study in Acute Treatment of Migraine

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Key Inclusion Criteria:~* Subjects with 2-8 moderate to severe migraines/month~* Age of onset of migraines prior to 50 years of age~* Migraine attacks, on average, lasting 4-72 hours if untreated~* Ability to distinguish migraine attacks from tension/cluster headaches~* Patients with contraindications for use of triptans may be included provided they meet all other study entry criteria~Key Exclusion Criteria:~* History of basilar migraine or hemiplegic migraine~* History of HIV disease~* History with current evidence of uncontrolled, unstable or recently diagnosed cardiovascular disease, such as ischemic heart disease, coronary artery vasospasm, and cerebral ischemia.~* Uncontrolled hypertension or uncontrolled diabetes (however, patients can be included who have stable hypertension and /or diabetes for 3 months prior to screening~* History of gastric or small intestinal surgery or has a disease that causes malabsorption~* BMI ≥ 30~* HbA1c ≥ 6.5%

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Rimegepant (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).